Martingale Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-40,100
| Closed | -$134K | – | 802 |
|
|
2023
Q1 | $134K | Sell |
40,100
-176,185
| -81% | -$590K | ﹤0.01% | 798 |
|
|
2022
Q4 | $1.04M | Sell |
216,285
-14,079
| -6% | -$67.7K | 0.02% | 440 |
|
|
2022
Q3 | $1.31M | Buy |
230,364
+84,140
| +58% | +$479K | 0.03% | 359 |
|
|
2022
Q2 | $1.04M | Buy |
146,224
+96
| +0.1% | +$682 | 0.02% | 456 |
|
|
2022
Q1 | $1.06M | Buy |
146,128
+49,051
| +51% | +$354K | 0.02% | 470 |
|
|
2021
Q4 | $868K | Buy |
97,077
+62,373
| +180% | +$558K | 0.01% | 531 |
|
|
2021
Q3 | $1.22M | Buy |
+34,704
| New | +$1.22M | 0.02% | 466 |
|